Literature DB >> 17713821

Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.

Chandrakanth Are1, John F Hsu, Ronald A Ghossein, Heiko Schoder, Jatin P Shah, Ashok R Shaha.   

Abstract

BACKGROUND: We previously reported a high incidence of primary thyroid cancer in fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid abnormalities. The aim of our study was to determine if these FDG-PET-detected thyroid malignancies represent a more-aggressive variant of primary thyroid carcinoma.
MATERIALS AND METHODS: All patients that underwent operative intervention for FDG-PET-detected incidental thyroid abnormalities were identified (June 2003 to April 2006). Patients with a diagnosis of primary thyroid carcinoma on final histopathology were included in the study. The patient demographics and histopathological findings were analyzed to identify adverse prognostic features.
RESULTS: In 11,500 patients, 17,250 FDG-PET scans were performed; 377 of these patients (3.2% of patients and 2.1% of FDG-PET scans) had findings positive for thyroid abnormality. Of the 32 patients that underwent operative intervention, 22 patients with a final diagnosis of primary thyroid malignancy were included in the study. A greater number of patients [12 patients, (54%)] were noted to harbor poor prognostic variants of primary thyroid carcinoma on final histopathology [tall-cell variant: 11 patients (50%) and poorly differentiated thyroid carcinoma: 1 patient (4%)]. Extra-thyroidal extension (ETE) was noted in the majority of patients [14 patients (63%)]. In patients with tall cell variant on final histopathology, the rate of ETE was even higher [10 patients (90%)].
CONCLUSION: Thyroid malignancies incidentally detected on FDG-PET scan harbor a high rate of unfavorable prognostic features and may represent a more-aggressive variant of primary thyroid carcinoma. These patients need to be subjected to further investigation with a view to possible operative intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713821     DOI: 10.1245/s10434-007-9531-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  25 in total

1.  Incidence and Significance of Incidental Focal Thyroid Uptake on (18)F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom.

Authors:  Kanhaiyalal Agrawal; James Weaver; Fahim Ul-Hassan; Jean-Pierre Jeannon; Ricard Simo; Paul Carroll; Johnathan G Hubbard; Ashish Chandra; Hosahalli Krishnamurthy Mohan
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.

Authors:  Hidefumi Nishimori; Roger Tabah; Marc Hickeson; Jacques How
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

3.  EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.

Authors:  Luca Giovanella; Anca M Avram; Ioannis Iakovou; Jennifer Kwak; Susan A Lawson; Elizabeth Lulaj; Markus Luster; Arnoldo Piccardo; Matthias Schmidt; Mark Tulchinsky; Frederick A Verburg; Ely Wolin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-07       Impact factor: 9.236

4.  Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.

Authors:  Heejin Kim; Kyung Jin Na; Jae Hyuk Choi; Byeong-Cheol Ahn; Dongbin Ahn; Jin Ho Sohn
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

5.  Controversies and challenges in the management of well-differentiated thyroid cancer.

Authors:  N Gopalakrishna Iyer; Ashok R Shaha
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

6.  Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?

Authors:  Silvia Morbelli; Marcello Bagnasco
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08       Impact factor: 9.236

Review 7.  Management of thyroid nodules and surgery for differentiated thyroid cancer.

Authors:  N G Iyer; A R Shaha
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-08       Impact factor: 4.126

8.  Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

Authors:  N Muñoz Pérez; J M Villar del Moral; M A Muros Fuentes; M López de la Torre; J I Arcelus Martínez; P Becerra Massare; D Esteva Martínez; M Cañadas Garre; E Coll Del Rey; P Bueno Laraño; J A Ferrón Orihuela
Journal:  Langenbecks Arch Surg       Date:  2013-04-28       Impact factor: 3.445

9.  Correlation of BRAF mutation and SUVmax levels in thyroid cancer patients incidentally detected in 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Aysenur Ozderya; Sule Temizkan; Aylin Ege Gul; Sule Ozugur; Mehmet Sargin; Kadriye Aydin
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

10.  FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.

Authors:  Hyun Woo Chung; Kye Young Lee; Hee Joung Kim; Wan Seop Kim; Young So
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.